Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

274.55
Delayed Data
As of Feb 11
 -5.22 / -1.87%
Today’s Change
237.50
Today|||52-Week Range
340.34
-12.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues4.1B4.2B5.8B4.1B
 
 
 
 
 
Cost of Goods Sold1.8B1.6B2.0B1.2B
 
 
 
 
 
Depreciation And Amortization938.0M982.6M1.7B1.6B
 
 
 
 
 
 
Operating ExpensesGross Income1.3B1.6B2.0B1.3B
 
 
 
 
 
General Expenses1.6B1.2B1.7B2.1B
 
 
 
 
 
Research And Development364.6M289.6M428.6M1.2B
 
 
 
 
 
Total Operating Expenses4.3B3.8B5.5B4.9B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-214.0M476.6M273.5M-769.7M
 
 
 
 
 
Extraordinary Credit----20.6M--
 
 
Extraordinary Charge-237.6M-798.5M-495.2M-578.2M
 
 
 
 
 
Interest Expense On Debt127.8M434.9M341.8M340.2M
 
 
 
 
 
Other Expenses-220.6M34.0M-8.6M4.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-794.9M-690.0M-548.9M-1.7B
 
 
 
 
 
Income Taxes-62.0M-177.7M-307.3M-824.9M
 
 
 
 
 
Minority Interest0.00-300.0K-1.5M-1.4M
 
 
 
 
Preferred Dividend---23.2M-69.6M-69.6M
 
 
 
 
Discontinued Operations0.000.000.006.2B
 
 
Net Income-732.9M-512.0M-243.1M5.3B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS265.1M289.5M392.6M393.6M
 
 
 
 
 
Shares To Calculate EPS Diluted265.1M289.5M392.6M393.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.76-$1.85-$0.80$13.29
 
 
 
 
 
EPS Diluted-$2.76-$1.85-$0.80$13.29